Application Note:
Technical Note (by request)
- VeriKine Mouse Interferon Alpha ELISA Kit Use with Tissue Homogenates
Background
Interferons (IFNs) are a group of cytokines which exhibit pleitropic activities that play major roles in both innate and adaptive immunity. Type I IFNs consist of multiple IFN-α genes and at least one IFN-β gene in most vertebrates, and a few other family members such as limitin in the mouse.1 There are 14 IFN-α subtypes in the mouse which share at least 75% identity in the protein sequence. In the human, IFN-α is used to treat viral diseases and cancer2-4 and is studied in mouse models of these diseases.5,6 Recent evidence has suggested that IFN-α may play a role in the development of certain autoimmune diseases7,8 and that treatment with IFN-α is useful for other autoimmune diseases.9
The expression of interferons is regulated by a group of interferon regulatory factor proteins (IRF). The expression of the individual IFN-α subtypes is regulated by the cellular levels of IRF3 and IRF7. Most of the IFN-α subtypes require IRF7 for expression. IRF7 is constitutively expressed in some cell types and is inducible in others. Inducible IRF7 expression is induced by IFN-β and IFN-α4 in mice and leads to expression of the other IFN-α subtypes. Murine IFN-β may be required for the production of IFN-α by fibroblasts but may not be required for IFN-α production by other cells.10 The IRF3/IRF7 signaling cascade is important for the initial and progressive responses to pathogens wherein hundreds of genes are regulated in a coordinated, temporal manner.11
Plasmacytoid dendritic cells are the major producers of IFN-α, but a large variety of cells can also produce lower levels of these proteins.12,13 The particular subtypes that are expressed appear to be somewhat cell and stimulus specific.14-16